Cited by 247Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 29 sources its claims cite is checked for support yet.

Is Ecstasy an “Empathogen”? Effects of +/- 3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

Open access
Bedi, Gillinder, Hyman, David, de Wit, Harriet·2010·Biological Psychiatry

Abstract

Background Users of ±3,4-methylenedioxymethamphetamine (MDMA), "ecstasy," report that the drug produces unusual psychological effects, including increased empathy and prosocial feelings. These "empathogenic" effects are cited as reasons for recreational ecstasy use and also form the basis for the proposed use of MDMA in psychotherapy. However, they have yet to be characterized in controlled studies. Here, we investigate effects of MDMA on an important social cognitive capacity, the identification of emotional expression in others, and on socially relevant mood states.Methods Over four sessions, healthy ecstasy-using volunteers (n = 21) received MDMA (.75, 1.5 mg/kg), methamphetamine (METH) (20 mg), and placebo under double-blind, randomized conditions. They completed self-report ratings of relevant affective states and undertook tasks in which they identified emotions from images of faces, pictures of eyes, and vocal cues.Results MDMA (1.5 mg/kg) significantly increased ratings of feeling "loving" and "friendly", and MDMA (.75 mg/kg) increased "loneliness". Both MDMA (1.5 mg/kg) and METH increased "playfulness"; only METH increased "sociability". MDMA (1.5 mg/kg) robustly decreased accuracy of facial fear recognition relative to placebo.Conclusions The drug MDMA increased "empathogenic" feelings but reduced accurate identification of threat-related facial emotional signals in others, findings consistent with increased social approach behavior rather than empathy. This effect of MDMA on social cognition has implications for both recreational and therapeutic use. In recreational users, acute drug effects might alter social risk-taking while intoxicated. Socioemotional processing alterations such as those documented here might underlie possible psychotherapeutic benefits of this drug; further investigation of such mechanisms could inform treatment design to maximize active components of MDMA-assisted psychotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2010.08.003

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

16 Not checked yet · 15 Own result · 12 Own interpretation · 8 Own method · 1 No basis given

Verify all 29 references — free account

Show all 27 claims

  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 13
25 of 25
  • The paper relies on this without support.

    Participants' guesses about which drug they received are a valid index of their expectancies.

    “There was no significant relationship between drug identification and any of the measures that were sensitive to drug effects.”
    “suggesting that expectancies play a minor role in these results.”
  • The paper relies on this without support.

    The FER, Eyes, and DANVA-2 tasks are comparable in their sensitivity to MDMA's effects on emotion recognition.

    “The effect of MDMA on social cognition was limited to identification of emotions from facial expressions, with no apparent effect on recognition of affective cues from the eye region or from voices.”
    “whereas the facial task required participants to identify emotions based on subtle, briefly presented pictures, there were no time limits on responding to items in the Eyes task.”
  • The paper relies on this without support.

    The study had sufficient statistical power to detect the reported effects and to support the null findings.

    “Over four sessions, healthy ecstasy-using volunteers (N=21) received MDMA (0.75mg/kg; 1.5mg/kg), methamphetamine (20mg; METH), and placebo (PBO) under double-blind, randomized conditions.”
    “MDMA did not affect accuracy on the Eyes or the DANVA-2 tests (Table 1).”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Not confirmedF(5.2, 104.6) = 3.23reported p = .008 · recomputed p = .009

    “F(5.2, 104.6) = 3.23, p = .008”

  • ConsistentF(3, 57) = 5.04reported p = .004 · recomputed p = .004

    “F(3,57) = 5.04, p = .004”

  • ConsistentF(2.7, 51) = 6.81reported p = .001 · recomputed p < .001

    “F(2.7,51) = 6.81, p = .001”

  • Consistentχ²(3) = 11.94reported p = .008 · recomputed p = .008

    “χ2(3) = 11.94, p = .008”

  • ConsistentF(3, 57) = 8.57reported p < .001 · recomputed p < .001

    “F(3,57) = 8.57, p < .001”

  • ConsistentF(2.5, 47.7) = 3.06reported p < .05 · recomputed p = .045

    “F(2.5, 47.7) = 3.06, p < .05”

  • ConsistentF(2.8, 56) = 4.45reported p = .008 · recomputed p = .008

    “F(2.8, 56.0) = 4.45, p = .008”

7 of 7

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 53 references

Cited by

Sorted by citations

See all 247

Metadata

Authors
Bedi, G., Hyman, D., & de Wit, H.
Affiliations
University of Chicago (US)
Corresponding author
Bedi, Gillinder
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2010-12
Volume
68
Issue
12
Pages
1134-1140
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1994271186
Cited by
247
References
53
Citations by year
2026: 12 · 2025: 20 · 2024: 23 · 2023: 38 · 2022: 8 · 2021: 12 · 2020: 13 · 2019: 10 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 13 · 2012: 9
FWCI
10.86
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (DA02812)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
MDMA, ecstasy, emotion recognition, methamphetamine, social cognition, MDMA-assisted psychotherapy, social approach behavior, loneliness, playfulness, sociability, recreational drug use
MeSH terms
Adolescent, Adult, Affect, Empathy, Facial Expression, Female, Humans, Male, Methamphetamine, Photic Stimulation, Psychomotor Performance, N-Methyl-3,4-methylenedioxyamphetamine, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review